- BGI Publishes Largest Ever Genomic Study of Chinese Population Discoveries in more than 140,000 Genomes throughout China
- BGI, NOAA Fisheries, and The Nature Conservancy Announce Partnership to Help Endangered Orcas
- BGI Signs Memorandum of Understanding with The University of Michigan
- China National GeneBank Signs a Colleboration Agreement with Queensland University on Scientific Research
- Establishment of the first Macaca fascicularis gut microbiome gene catalog
- Establishing the first gene catalogue of Sprague-Dawley rat gut metagenome based on the BGISEQ-500 platform
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
Tel: +86-755-36307212Email: firstname.lastname@example.org
Copenhagen, Denmark, and Ghent, Belgium, January 24, 2013 — Hundreds of researchers and experts from all over the world are scheduled to convene in Ghent, Belgium, from June 25-28 for the 2013 International Conference on Genomics in Europe (ICG-Europe 2013). The conference, co-organized by BGI and VIB, will feature cutting-edge research, focusing on the latest developments in plant and animal genomics, metagenomics, as well as the the growing application of next-gen sequencing and advanced bioinformatics in the fields such as human diseases, biomedical research, and translational medicine.
The three-day conference will consist of 11 sessions featuring over 60 presentations. Included among the featured speakers will be scientists and university leaders, company directors, senior executives and CEOs from Belgium, Netherlands, Italy, Germany, U.S.A., Denmark, Australia, United Kingdom, France, China, etc . Ample networking opportunities are available for attendees to exchange views and discuss the latest advances and applications of Omics technologies. Researchers from around the globe are invited to attend ICG-2013.
Besides these sessions, two parallel workshops will be held at ICG Europe. The workshop “Innovation-Entrepreneurship in Venture Creation”, will feature talks on launching spinout companies from research institutes, and will offer insights into VC and Pharma Venture arms view in investments in the genomics industry. The second workshop has a focus on ELSIs capturing the multi-dimensional issues and interrelationship among Environment, Health and Society.
It is the second time that BGI, the world largest genomic research organization, to bring Europe its acclaimed International Conference on Genomics (ICG). The first ICG-Europe was successfully conducted in Copenhagen, Denmark last May. "The past ICG Europe has achieved great success. This year we are excited to present the 2nd ICG Europe in Ghent.” said Professor Huanming Yang, Chairman of BGI, “I believe it will provide an excellent opportunity for researchers, academia and industries to exchange ideas, share the latest findings and to form new collaborations in Genomics and related fields.
Professor Hans Galjaard, Chairman of the Department of Clinical Genetics at Erasmus University, Netherlands, said, “In 1983 I visited China for the first time as a member of a small U.N delegation to discuss human reproduction and preventive genetics. Remembering the facilities then available it is impressive how genomics research has developed to a high standard. Also from the beginning of this century public debates were organized about the psychosocial and ethical aspects of the new technologies. After previous successful ICG conferences in China, U.S.A and Europe from 2004 on, I am convinced that this present ICG conference will also be very fruitful. Are you seeking a strategic partner or external expertise to enhance your development, or are you looking to learn about the latest advance in genomics, discover how industry, academia and clinicians are collaborating to drive forward research and development, then we invite you to the three-day ICG conference in Ghent, tailor-made for you to explore the genomics world. ”
ICG Europe 2013 will be held at Ghent University located in Ghent, a beautiful, cozy and ancient city in Belgium. Learn more information, please visit: http://www.icg-europe.org/
VIB is a life sciences research institute in Flanders, Belgium. With more than 1200 scientists from over 60 countries, we perform basic research into the molecular foundations of life. VIB is an excellence-based entrepreneurial institute that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications. VIB works in close partnership with four universities − UGent, K.U.Leuven, University of Antwerp and Vrije Universiteit Brussel, and is funded by the Flemish government. VIB develops and disseminates a wide range of science-based information about all aspects of biotechnology. For more information about VIB, please visit http://www.vib.be/en/Pages/default.aspx.
Marketing Communication Manager
+45 8173 0147